Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Nov;82(21):7414-8.
doi: 10.1073/pnas.82.21.7414.

Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors

Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors

J P McKearn et al. Proc Natl Acad Sci U S A. 1985 Nov.

Abstract

A simple one-step isolation technique significantly enriched mouse fetal liver cells that respond to interleukin 3 (IL-3), a multilineage hematopoietic growth factor. The fetal liver cell subpopulation isolated with monoclonal antibody AA4 contained 50- to 100-fold higher frequencies of multipotential (CFU-mix) or restricted (CFU-G/M, BFU-E) erythroid/myeloid precursors as well as precursors that differentiate to become mature B lymphocytes [CFU-mix = erythroid and myeloid colony-forming unit(s); CFU-G/M = CFU-granulocyte/macrophage; BFU-E = burst-forming unit-erythroid]. The B-lymphocyte precursors could be cloned in single-cell cultures when IL-3-containing supernatants were present. Growth of these clones was supported by purified IL-3 but not by purified IL-2. Stable growth has been maintained for greater than 6 mo in the presence of IL-3. Such clones express on their cell surface low amounts of class I major histocompatibility complex antigens and high amounts of AA4, GF1, and leukocyte common glycoprotein 200 antigens. They lack detectable rearrangements of their Ig-encoding genes [joining region heavy and light (kappa, lambda) chain genes], even after subcloning, but maintain their capacity to differentiate to mature B lymphocytes committed to multiple Ig specificities.

PubMed Disclaimer

References

    1. Eur J Immunol. 1973 Jul;3(7):392-7 - PubMed
    1. Eur J Immunol. 1985 Mar;15(3):295-8 - PubMed
    1. J Exp Med. 1976 May 1;143(5):1265-70 - PubMed
    1. J Immunol. 1978 Jun;120(6):2027-32 - PubMed
    1. Eur J Immunol. 1978 Aug;8(8):539-51 - PubMed

Publication types